Abzena logo

ABZA - Abzena Share Price

15.75p 0.0  0.0%

Last Trade - 10/10/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £22.0m
Position in Universe th / 1805
Bullish
Bearish
Unlock ABZA Revenue
Momentum
Relative Strength (%)
1m -0.93%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
3.90 3.78 5.67 9.85 18.7 22.0 26.8 34.9 +41.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2018, Abzena PLCrevenues increased 18% to £22M. Net loss increased 55% to£14.2M. Revenues reflect Product development &biomanufacturing segment increase of 77% to £7.3M, ProteinEngineering segment increase of 32% to £2M, Other segmentincrease from £960K to £2.3M, United Kingdom segmentincrease of 87% to £1.5M. Higher net loss reflectsAdministrative expenses increase of 8% to £15.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ABZA Revenue Unlock ABZA Revenue

Net Income

ABZA Net Income Unlock ABZA Revenue

Normalised EPS

ABZA Normalised EPS Unlock ABZA Revenue

PE Ratio Range

ABZA PE Ratio Range Unlock ABZA Revenue

Dividend Yield Range

ABZA Dividend Yield Range Unlock ABZA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ABZA EPS Forecasts Unlock ABZA Revenue
Profile Summary

Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups. It offers immunogenicity assessment, which includes EpiScreen, iTope and T Cell Epitope Database (TCED); antibody drug conjugates, which includes ThioBridge linkers; antibody, which includes Composite Human Antibodies and Composite Proteins; optimization of pharmacokinetics, which includes TheraPEG, HiPEG conjugates PEG to poly-histidine motifs and CyPEG, and PolyPEG; cell line development, which includes Composite Human Antibody; process development, Good manufacturing practices (GMP) manufacturing, and small molecules. The Company's Abzena inside includes Composite Human Antibodies and ThioBridge Antibody Drug Conjugates (ADCs).

Directors
Last Annual March 31st, 2018
Last Interim March 31st, 2018
Incorporated March 25, 2014
Public Since July 10, 2014
No. of Shareholders: n/a
No. of Employees: 236
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange London Stock Exchange
Shares in Issue 214,893,379
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ABZA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ABZA
Upcoming Events for ABZA
Frequently Asked Questions for Abzena
What is the Abzena share price?

As of 10/10/18, shares in Abzena are trading at 15.75p, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Abzena share price performed this year?

Shares in Abzena are currently trading at 15.75p and the price has moved by -51.91% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Abzena price has moved by -47.68% over the past year.

What are the analyst and broker recommendations for Abzena?

Of the analysts with advisory recommendations for Abzena, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Abzena is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Abzena next release its financial results?

Abzena is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-03-31
What is the Abzena dividend yield?

Abzena does not currently pay a dividend.

Does Abzena pay a dividend?

Abzena does not currently pay a dividend.

When does Abzena next pay dividends?

Abzena does not currently pay a dividend.

How do I buy Abzena shares?

To buy shares in Abzena you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Abzena?

Shares in Abzena are currently trading at 15.75p, giving the company a market capitalisation of £n/a.

Where are Abzena shares listed? Where are Abzena shares listed?

Here are the trading details for Abzena:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: ABZA
What kind of share is Abzena?

We were not able to load our ranking data for Abzena

Is there a Abzena share price forecast 2021?

We were not able to load any forecast data for Abzena.

How can I tell whether the Abzena share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abzena. Over the past six months, the relative strength of its shares against the market has been -29.05%. At the current price of 15.75p, shares in Abzena are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Abzena PE Ratio?

We were not able to find PE ratio data for Abzena.

Who are the key directors of Abzena?

We were unable to find the directors for Abzena.

Who are the major shareholders of Abzena?

Here are the top five shareholders of Abzena based on the size of their shareholding:

Similar to ABZA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.